| Year |
Title |
Altmetric |
| 2022
|
Real-World Data on Cutaneous Recurrences Following Neonatal Herpes Simplex Virus Disease.
Journal of the Pediatric Infectious Diseases Society.
11:504-505.
2022
|
|
| 2022
|
Cytomegalovirus variation among newborns treated with valganciclovir.
Antiviral Research.
203.
2022
|
|
| 2022
|
The Changing Landscape of Neonatal Herpes Simplex Virus Disease.
Journal of the Pediatric Infectious Diseases Society.
11:121-123.
2022
|
|
| 2022
|
COVID-19 Vaccines in Children and Adolescents.
Pediatrics.
149.
2022
|
|
| 2021
|
Unraveling the enigma of neonatal herpes: A novel tool for assessing risk of infection.
Pediatrics.
148.
2021
|
|
| 2021
|
Variation in Diagnostic Testing and Empiric Acyclovir Use for HSV Infection in Febrile Infants..
Hospital pediatrics.
11:922-930.
2021
|
|
| 2021
|
Clinical outcome and the role of antivirals in congenital cytomegalovirus infection.
Antiviral Research.
191.
2021
|
|
| 2021
|
Neonatal Herpes Simplex Virus Disease: Updates and Continued Challenges.
Clinics in Perinatology.
48:263-274.
2021
|
|
| 2021
|
COVID-19 Vaccination of Adolescents and Young Adults of Color: Viewing Acceptance and Uptake With a Health Equity Lens.
Journal of Adolescent Health.
68:844-846.
2021
|
|
| 2021
|
Initial guidance on use of monoclonal antibody therapy for treatment of coronavirus disease 2019 in children and adolescents.
Journal of the Pediatric Infectious Diseases Society.
10:629-634.
2021
|
|
| 2021
|
Policy Statement: Antibiotic stewardship in pediatrics.
Journal of the Pediatric Infectious Diseases Society.
10:641-649.
2021
|
|
| 2021
|
Neonatal brain injury from sars-cov-2: Fact or fiction?
2021
|
|
| 2021
|
Recommended childhood and adolescent immunization schedule: United States, 2021.
Pediatrics.
147.
2021
|
|
| 2021
|
Balancing Risks in the Time of COVID-19.
JAMA Pediatrics.
175:129-130.
2021
|
|
| 2021
|
Breast Milk and COVID-19: What Do We Know?.
Clinical Infectious Diseases.
72:131-132.
2021
|
|
| 2021
|
Multicenter Interim Guidance on Use of Antivirals for Children with Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Journal of the Pediatric Infectious Diseases Society.
10:34-48.
2021
|
|
| 2021
|
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
Obstetrical and Gynecological Survey.
76:10-13.
2021
|
|
| 2020
|
COVID-19 and the law of unforeseen consequences.
Pediatrics.
146.
2020
|
|
| 2020
|
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Journal of the Pediatric Infectious Diseases Society.
9:701-715.
2020
|
|
| 2020
|
Update From the Advisory Committee on Immunization Practices.
Journal of the Pediatric Infectious Diseases Society.
9:645-649.
2020
|
|
| 2020
|
COVID-19 and the Law of Unforeseen Consequences.
Pediatrics.
146.
2020
|
|
| 2020
|
Clinical Investigator Training Program (CITP) – A practical and pragmatic approach to conveying clinical investigator competencies and training to busy clinicians.
Contemporary Clinical Trials Communications.
19.
2020
|
|
| 2020
|
Respiratory syncytial virus vaccination during pregnancy and effects in infants.
New England Journal of Medicine.
383:426-439.
2020
|
|
| 2020
|
Can SARS-CoV-2 Infection Be Acquired in Utero?: More Definitive Evidence Is Needed.
Journal of the American Medical Association.
323:1788-1789.
2020
|
|
| 2020
|
Advances in the development of therapeutics for cytomegalovirus infections.
Journal of Infectious Diseases.
221:32-44.
2020
|
|
| 2019
|
Update from the Advisory Committee on Immunization Practices.
Journal of the Pediatric Infectious Diseases Society.
8:495-500.
2019
|
|
| 2019
|
Update from the Advisory Committee on Immunization Practices.
Journal of the Pediatric Infectious Diseases Society.
9:3-5.
2019
|
|
| 2019
|
Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.
Journal of Infectious Diseases.
219:1398-1406.
2019
|
|
| 2019
|
Neonatal herpes simplex virus infection among Medicaid-enrolled children: 2009–2015.
Pediatrics.
143.
2019
|
|
| 2019
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
8:379-383.
2019
|
|
| 2019
|
Genotypic and phenotypic diversity of herpes simplex virus 2 within the infected neonatal population.
Clinical and Vaccine Immunology.
4.
2019
|
|
| 2019
|
Recommendations for prevention and control of influenza in children, 2019–2020.
Pediatrics.
144.
2019
|
|
| 2018
|
Update From the Advisory Committee on Immunization Practices.
Journal of the Pediatric Infectious Diseases Society.
7:270-274.
2018
|
|
| 2018
|
The tail wagging the dog (or the challenges faced when the financing of medicine gets ahead of the science of medicine).
Journal of Clinical Microbiology.
56.
2018
|
|
| 2018
|
Antiviral approaches for the treatment of herpes simplex virus infections in Newborn Infants.
Annual Review of Virology.
5:407-425.
2018
|
|
| 2018
|
Update From the Advisory Committee on Immunization Practices.
Journal of the Pediatric Infectious Diseases Society.
7:181-187.
2018
|
|
| 2018
|
Closer to Universal Newborn Screening for Congenital Cytomegalovirus Infection but Far Away from Antiviral Therapy in All Infected Infants.
Journal of Pediatrics.
199:7-9.
2018
|
|
| 2018
|
Antiviral treatment of childhood influenza: An update.
Current Opinion in Pediatrics.
30:438-447.
2018
|
|
| 2018
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
7:93-99.
2018
|
|
| 2018
|
Fulminant Haemophilus Influenzae Type a Infection in a 4-year-old with Previously Undiagnosed Asplenic Heterotaxy
2018
|
|
| 2018
|
Neonatal herpes simplex virus infections.
Seminars in Perinatology.
42:168-175.
2018
|
|
| 2018
|
Neonatal HSV disease: Balancing the low incidence with the need to treat promptly.
Pediatrics.
141.
2018
|
|
| 2018
|
Neonatal herpes simplex virus infection
2018
|
|
| 2018
|
Clinical markers and outcomes of neonates with herpes simplex virus deoxyribonucleic acid persistence in cerebrospinal fluid in disseminated and central nervous system infection.
Journal of the Pediatric Infectious Diseases Society.
7:E30-E33.
2018
|
|
| 2017
|
Antiviral Drugs in Newborn and Children.
Pediatric Clinics of North America.
64:1403-1415.
2017
|
|
| 2017
|
Delayed recurrence of herpes simplex virus infection in the central nervous system after neonatal infection and completion of six months of suppressive therapy.
Journal of the Pediatric Infectious Diseases Society.
6:e177-e179.
2017
|
|
| 2017
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
6:311-316.
2017
|
|
| 2017
|
Intravenous zanamivir in hospitalized patients with influenza.
Pediatrics.
140.
2017
|
|
| 2017
|
Update: Interim guidance for the diagnosis, evaluation, and management of infants with possible congenital zika virus infection - United States, October 2017
2017
|
|
| 2017
|
Assessing the febrile child for serious infection: A step closer to meaningful rapid results.
Pediatrics.
140.
2017
|
|
| 2017
|
Elimination of perinatal hepatitis B: Providing the first vaccine dose within 24 hours of birth.
Pediatrics.
140.
2017
|
|
| 2017
|
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.
Lancet Infectious Diseases.
17:e177-e188.
2017
|
|
| 2017
|
Preventing human papillomavirus–related cancers: we are all in this together.
American Journal of Obstetrics and Gynecology.
216:576.e1-576.e5.
2017
|
|
| 2017
|
Update from the Advisory Committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
6:111-115.
2017
|
|
| 2017
|
Congenital Cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatment.
Italian Journal of Pediatrics.
43.
2017
|
|
| 2017
|
Why neonatal herpes matters
2017
|
|
| 2017
|
Screening for congenital cytomegalovirus after newborn hearing screening: What comes next?.
Pediatrics.
139.
2017
|
|
| 2017
|
Pathogenesis of Non-Zika Congenital Viral Infections.
Journal of Infectious Diseases.
216:S912-S918.
2017
|
|
| 2016
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
5:349-355.
2016
|
|
| 2016
|
Countering vaccine hesitancy.
Pediatrics.
138.
2016
|
|
| 2016
|
Medical versus nonmedical immunization exemptions for child care and school attendance.
Pediatrics.
138.
2016
|
|
| 2016
|
Parental presence during treatment of ebola or other highly consequential infection.
Pediatrics.
138.
2016
|
|
| 2016
|
Recommendations for serogroup B meningococcal vaccine for persons 10 years and older.
Pediatrics.
138.
2016
|
|
| 2016
|
Vaccine delays, refusals, and patient dismissals: A survey of pediatricians.
Pediatrics.
138.
2016
|
|
| 2016
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
5:101-104.
2016
|
|
| 2016
|
Advances in the prevention and treatment of congenital cytomegalovirus infection.
Current Opinion in Pediatrics.
28:81-85.
2016
|
|
| 2015
|
Sequelae following postnatally acquired cytomegalovirus infection in very low-birth-weight neonates back to the future.
JAMA Pediatrics.
169.
2015
|
|
| 2015
|
A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis.
Journal of the Pediatric Infectious Diseases Society.
5:53-62.
2015
|
|
| 2015
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
5:3-6.
2015
|
|
| 2015
|
Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease.
Obstetrical and Gynecological Survey.
70:489-490.
2015
|
|
| 2015
|
The authors reply.
New England Journal of Medicine.
372:2463.
2015
|
|
| 2015
|
Acyclovir dosing and acute kidney injury: Deviations and direction.
Journal of Pediatrics.
166:1341-1344.
2015
|
|
| 2015
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
4:94-95.
2015
|
|
| 2015
|
Valganciclovir for symptomatic congenital cytomegalovirus disease.
New England Journal of Medicine.
372:933-943.
2015
|
|
| 2015
|
Neonatal herpes simplex virus infection: Epidemiology and treatment.
Clinics in Perinatology.
42:47-59.
2015
|
|
| 2015
|
Neonatal Herpes Simplex Virus Infection.
Infectious Disease Clinics of North America.
29:391-400.
2015
|
|
| 2015
|
Quantitative herpes simplex virus concentrations in neonatal infection.
Journal of Pediatrics.
166:793-795.
2015
|
|
| 2014
|
Authors' responses in response to the letter from Ambrose.
Pediatrics.
134:e1782-e1783.
2014
|
|
| 2014
|
Preventing herpes simplex virus in the newborn.
Clinics in Perinatology.
41:945-955.
2014
|
|
| 2014
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
3:282-285.
2014
|
|
| 2014
|
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.
Pediatrics.
134:415-420.
2014
|
|
| 2014
|
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.
Pediatrics.
134.
2014
|
|
| 2014
|
Updated recommendations on the use of meningococcal vaccines.
Pediatrics.
134:400-403.
2014
|
|
| 2014
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
3:94-97.
2014
|
|
| 2014
|
Recommended childhood and adolescent immunization schedule - United States, 2014.
Pediatrics.
133:357-363.
2014
|
|
| 2014
|
The scarlet H.
Journal of Infectious Diseases.
209:315-317.
2014
|
|
| 2014
|
Authors' response re: Clarifying costs and benefits of respiratory syncytial virus immunoprophylaxis.
Pediatrics.
133.
2014
|
|
| 2014
|
Management of neonatal herpes simplex virus infection and exposure
2014
|
|
| 2014
|
Mother-to-child transmission of herpes simplex virus.
Journal of the Pediatric Infectious Diseases Society.
3.
2014
|
|
| 2014
|
Pediatric anthrax clinical management.
Pediatrics.
133.
2014
|
|
| 2014
|
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.
Clinical Pharmacology and Therapeutics.
96:380-389.
2014
|
|
| 2014
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
3:1-3.
2014
|
|
| 2013
|
Executive summary: Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: Recommendations from the national institutes of health, the centers for disease control and prevention, the HIV medicine association of the infectious diseases society of America, the pediatric infectious diseases society, and the American academy of pediatrics.
Journal of the Pediatric Infectious Diseases Society.
2:293-308.
2013
|
|
| 2013
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
2:309-311.
2013
|
|
| 2013
|
RSV immunoprophylaxis: Does the benefit justify the cost?.
Pediatrics.
132:915-918.
2013
|
|
| 2013
|
Recommendations for prevention and control of influenza in children, 2013-2014.
Pediatrics.
132.
2013
|
|
| 2013
|
A conversation with David w. Kimberlin, MD, FAAP
2013
|
|
| 2013
|
Neonatal Herpes Simplex Virus Infections.
Pediatric Clinics of North America.
60:351-365.
2013
|
|
| 2013
|
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
Journal of Infectious Diseases.
207:709-720.
2013
|
|
| 2013
|
Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
Pediatrics.
131.
2013
|
|
| 2013
|
Guidance on management of asymptomatic neonates born to women with active genital herpes lesions..
Pediatrics.
131:383-386.
2013
|
|
| 2013
|
Maternal and neonatal herpes simplex virus infections.
American Journal of Perinatology.
30:113-120.
2013
|
|
| 2013
|
Acyclovir dosing in the neonatal period and beyond.
Journal of the Pediatric Infectious Diseases Society.
2:179-182.
2013
|
|
| 2013
|
Update from the advisory committee on immunization practices.
Journal of the Pediatric Infectious Diseases Society.
2:97-99.
2013
|
|
| 2012
|
Epidemiology and diagnosis of health care - Associated infections in the NICU.
Pediatrics.
129.
2012
|
|
| 2012
|
Recommended childhood and adolescent immunization schedules - United States, 2012.
Pediatrics.
129:385-386.
2012
|
|
| 2012
|
The authors reply.
New England Journal of Medicine.
366:90-91.
2012
|
|
| 2012
|
Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: A multicenter case series.
Journal of Pediatrics.
161.
2012
|
|
| 2012
|
Recommendations for prevention and control of influenza in children, 2012-2013.
Pediatrics.
130:780-792.
2012
|
|
| 2011
|
Meningococcal conjugate vaccines policy update: Booster dose recommendations.
Pediatrics.
128:1213-1218.
2011
|
|
| 2011
|
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
New England Journal of Medicine.
365:1284-1292.
2011
|
|
| 2011
|
Poliovirus.
Pediatrics.
128:805-808.
2011
|
|
| 2011
|
Recommendations for administering hepatitis A vaccine to contacts of international adoptees.
Pediatrics.
128:803-804.
2011
|
|
| 2011
|
The use of systemic and topical fluoroquinolones.
Pediatrics.
128.
2011
|
|
| 2011
|
Policy statement - Prevention of varicella: Update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.
Pediatrics.
128:630-632.
2011
|
|
| 2011
|
Policy statement - Recommendations for the prevention of perinatal group B streptococcal (GBS) disease.
Pediatrics.
128:611-616.
2011
|
|
| 2011
|
Policy statement - Rabies-prevention policy update: New reduced-dose schedule.
Pediatrics.
127:785-787.
2011
|
|
| 2011
|
Control of varicella disease, version 2.0.
Journal of Infectious Diseases.
203:297-298.
2011
|
|
| 2011
|
Policy statement - Recommended childhood and adolescent immunization schedules - United States, 2011.
Pediatrics.
127:387-388.
2011
|
|
| 2010
|
Determination of appropriate dosing of influenza drugs in pediatric patients.
Clinical Pharmacology and Therapeutics.
88:704-707.
2010
|
|
| 2010
|
Policy statement - Recommendation for mandatory influenza immunization of all health care personnel.
Pediatrics.
126:809-815.
2010
|
|
| 2010
|
Policy statement - Recommendations for prevention and control of influenza in children, 2010-2011.
Pediatrics.
126:816-826.
2010
|
|
| 2010
|
Oseltamivir dosing for influenza infection in premature neonates.
Journal of Infectious Diseases.
202:563-566.
2010
|
|
| 2010
|
Clinical report - Head lice.
Pediatrics.
126:392-403.
2010
|
|
| 2010
|
Policy statement - Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: Use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23).
Pediatrics.
126:186-190.
2010
|
|
| 2010
|
Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
Clinical Infectious Diseases.
50:221-228.
2010
|
|
| 2010
|
Policy statement - Recommended childhood and adolescent immunization schedules - United States, 2010.
Pediatrics.
125:195-196.
2010
|
|
| 2010
|
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age
2010
|
|
| 2010
|
Targeted antiviral prophylaxis with oseltamivir in a summer camp setting.
JAMA Pediatrics.
164:323-327.
2010
|
|
| 2009
|
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.
Journal of Clinical Virology.
46.
2009
|
|
| 2009
|
Policy statement - Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.
Pediatrics.
124:1694-1701.
2009
|
|
| 2009
|
The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.
Pediatrics.
124:1676-1679.
2009
|
|
| 2009
|
Policy statement - Recommendations for the prevention and treatment of influenza in children, 2009-2010.
Pediatrics.
124:1216-1226.
2009
|
|
| 2009
|
Antiviral therapy for herpesvirus central nervous system infections: Neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.
Antiviral Research.
83:207-213.
2009
|
|
| 2009
|
Drinking water from private wells and risks to children.
Pediatrics.
123:1599-1605.
2009
|
|
| 2009
|
Drinking water from private wells and risks to children.
Pediatrics.
123.
2009
|
|
| 2009
|
Prevention of rotavirus disease: Updated guidelines for use of rotavirus vaccine.
Pediatrics.
123:1412-1420.
2009
|
|
| 2009
|
Treatment of congenital cytomegalovirus infection: Implications for future therapeutic strategies.
Journal of Antimicrobial Chemotherapy.
63:862-867.
2009
|
|
| 2009
|
Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review..
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
14:86-93.
2009
|
|
| 2008
|
Exposure to nontraditional pets at home and to animals in public settings: Risks to children.
Pediatrics.
122:876-886.
2008
|
|
| 2008
|
When Should You Initiate Acyclovir Therapy in a Neonate?.
Journal of Pediatrics.
153:155-156.
2008
|
|
| 2008
|
Prevention of influenza: Recommendations for influenza immunization of children, 2007-2008.
Pediatrics.
121.
2008
|
|
| 2008
|
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
Journal of Infectious Diseases.
197:836-845.
2008
|
|
| 2008
|
Prevention of influenza: Recommendations for influenza immunization of children, 2008-2009.
Pediatrics.
122:1135-1141.
2008
|
|
| 2008
|
Recommended immunization schedules for children and adolescents - United States, 2008.
Pediatrics.
121:219-220.
2008
|
|
| 2007
|
Infection prevention and control in pediatric ambulatory settings.
Pediatrics.
120:650-665.
2007
|
|
| 2007
|
Prevention of human papillomavirus infection: Provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine.
Pediatrics.
120:666-668.
2007
|
|
| 2007
|
Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
Pediatrics.
120:221-231.
2007
|
|
| 2007
|
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.
Clinical Pharmacology and Therapeutics.
81:867-872.
2007
|
|
| 2007
|
Management of HSV encephalitis in adults and neonates: Diagnosis, prognosis and treatment.
Herpes : the journal of the IHMF.
14:11-16.
2007
|
|
| 2007
|
Antiviral therapy and prophylaxis for influenza in children.
Pediatrics.
119:852-860.
2007
|
|
| 2007
|
Prevention of influenza: Recommendations for influenza immunization of children, 2006-2007.
Pediatrics.
119:846-851.
2007
|
|
| 2007
|
Varicella-zoster vaccine for the prevention of herpes zoster.
New England Journal of Medicine.
356:1338-1343.
2007
|
|
| 2007
|
Herpes Simplex Virus Infections of the Newborn.
Seminars in Perinatology.
31:19-25.
2007
|
|
| 2007
|
Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine.
Pediatrics.
119:171-181.
2007
|
|
| 2007
|
Recommended immunization schedules for children and adolescents-United States, 2007.
Pediatrics.
119:207-208.
2007
|
|
| 2007
|
Reply.
American Journal of Obstetrics and Gynecology.
196.
2007
|
|
| 2006
|
The use of systemic fluoroquinolones.
Pediatrics.
118:1287-1292.
2006
|
|
| 2006
|
Prevention of pertussis among adolescents: Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
Pediatrics.
117:965-978.
2006
|
|
| 2006
|
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
American Journal of Obstetrics and Gynecology.
194:774-781.
2006
|
|
| 2006
|
Diagnosis of herpes simplex virus in the era of polymerase chain reaction
2006
|
|
| 2005
|
Diagnosis of herpes simplex virus infections of the CNS
2005
|
|
| 2005
|
Antiviral therapies in children: Has their time arrived?.
Pediatric Clinics of North America.
52:837-867.
2005
|
|
| 2005
|
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.
Journal of Infectious Diseases.
191:227-233.
2005
|
|
| 2005
|
Herpes simplex virus infections in neonates and early childhood.
Seminars in pediatric infectious diseases.
16:271-281.
2005
|
|
| 2005
|
Herpes simplex: Encephalitis children and adolescents.
Seminars in pediatric infectious diseases.
16:17-23.
2005
|
|
| 2005
|
Neonatal herpes: What have we learned.
Seminars in pediatric infectious diseases.
16:7-16.
2005
|
|
| 2005
|
Seminars in Pediatric Infectious Diseases: Introduction.
Seminars in pediatric infectious diseases.
16:4-5.
2005
|
|
| 2004
|
Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
Antiviral Research.
63:141-151.
2004
|
|
| 2004
|
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis) - Resistant mutants.
Journal of Infectious Diseases.
190:975-978.
2004
|
|
| 2004
|
Neonatal HSV infections: The global picture.
Herpes : the journal of the IHMF.
11:31-32.
2004
|
|
| 2004
|
Genital Herpes.
New England Journal of Medicine.
350:1970-1977+2017.
2004
|
|
| 2004
|
Clinical practice. Genital herpes..
New England Journal of Medicine.
350:1970-1977.
2004
|
|
| 2004
|
Neonatal Herpes Simplex Infection.
Clinical Microbiology Reviews.
17:1-13.
2004
|
|
| 2003
|
Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trial.
Pediatrics.
112:363-367.
2003
|
|
| 2003
|
Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial..
Pediatrics.
112:363-367.
2003
|
|
| 2003
|
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial.
Journal of Pediatrics.
143:16-25.
2003
|
|
| 2003
|
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
2003
|
|
| 2003
|
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.
2003
|
|
| 2003
|
Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients
2003
|
|
| 2003
|
Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients.
2003
|
|
| 2003
|
Herpes simplex virus infections of the central nervous system.
Seminars in pediatric infectious diseases.
14:83-89.
2003
|
|
| 2003
|
Molecular diagnosis of viral infections of the central nervous system.
Clinics in Laboratory Medicine.
23:843-865.
2003
|
|
| 2002
|
Herpes simplex virus infections in the neonatal period.
Infections in medicine.
19:462-474.
2002
|
|
| 2002
|
Pharmacotherapy of recurrent respiratory papillomatosis.
Expert Opinion on Pharmacotherapy.
3:1091-1099.
2002
|
|
| 2002
|
Meningitis in the Neonate..
Current Treatment Options in Neurology.
4:239-248.
2002
|
|
| 2002
|
Antiretroviral pharmacokinetics in the paediatric population: A review.
Clinical Pharmacokinetics.
41:1115-1133.
2002
|
|
| 2002
|
Antiviral therapy for cytomegalovirus infections in pediatric patients.
Seminars in pediatric infectious diseases.
13:22-30.
2002
|
|
| 2001
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era.
Pediatrics.
108:223-229.
2001
|
|
| 2001
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
Pediatrics.
108:230-238.
2001
|
|
| 2001
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era..
Pediatrics.
108:223-229.
2001
|
|
| 2001
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections..
Pediatrics.
108:230-238.
2001
|
|
| 2001
|
Advances in the treatment of neonatal herpes simplex infections.
Reviews in Medical Virology.
11:157-163.
2001
|
|
| 2001
|
Acyclovir derivatives and other new antiviral agents.
Seminars in pediatric infectious diseases.
12:224-234.
2001
|
|
| 2000
|
Juvenile onset recurrent respiratory papillomatosis: Possibilities for successful antiviral therapy.
Antiviral Research.
45:83-93.
2000
|
|
| 1999
|
Indicated versus spontaneous preterm delivery: An evaluation of neonatal morbidity among infants weighing ≤1000 grams at birth.
American Journal of Obstetrics and Gynecology.
180:683-689.
1999
|
|
| 1999
|
Neuroinvasion of human herpesviruses 6 and 7.
Herpes : the journal of the IHMF.
6:60-63.
1999
|
|
| 1999
|
Viral encephalitis..
Pediatrics in Review.
20:192-198.
1999
|
|
| 1998
|
PCR: A new diagnostic tool that re-defines spectrum of HSV disease.
Herpes : the journal of the IHMF.
5:42-45.
1998
|
|
| 1998
|
Bacterial vaginosis: Association with adverse pregnancy outcome.
Seminars in Perinatology.
22:242-250.
1998
|
|
| 1998
|
Burkitt lymphoma in pregnancy.
Obstetrics and Gynecology.
92:675-678.
1998
|
|
| 1998
|
Fetal heart rate characteristics at 25 to 28 weeks' gestation.
American Journal of Perinatology.
15:507-510.
1998
|
|
| 1998
|
Herpes simplex viruses.
Clinical Infectious Diseases.
26:541-555.
1998
|
|
| 1998
|
Human herpesvirus-6: Neurologic implications of a newly-described viral pathogen.
Journal of NeuroVirology.
4:474-485.
1998
|
|
| 1998
|
Human herpesviruses 6 and 7: Identification of newly recognized viral pathogens and their association with human disease
1998
|
|
| 1998
|
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
American Journal of Obstetrics and Gynecology.
179:846-851.
1998
|
|
| 1998
|
Prevention and treatment of congenitally and perinatally acquired herpesvirus infections.
International Antiviral News.
6:78-82.
1998
|
|
| 1998
|
The effect of maternal magnesium sulfate treatment on neonatal morbidity in ≤ 1000-gram infants.
American Journal of Perinatology.
15:635-641.
1998
|
|
| 1997
|
Prophylaxis and treatment of herpesvirus infections in children.
Seminars in pediatric infectious diseases.
8:196-204.
1997
|
|
| 1997
|
Rubella immunization
1997
|
|
| 1997
|
Treatment of viral infections during pregnancy and the neonatal period.
Clinics in Perinatology.
24:267-283.
1997
|
|
| 1996
|
Antiviral resistance: Mechanisms, clinical significance, and future implications.
Journal of Antimicrobial Chemotherapy.
37:403-421.
1996
|
|
| 1996
|
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial
1996
|
|
| 1996
|
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease.
Journal of Infectious Diseases.
174:1162-1167.
1996
|
|
| 1995
|
Protein synthesis-dependent induction of interleukin-1β by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells.
Journal of Clinical Immunology.
15:199-204.
1995
|
|
| 1995
|
Antiviral resistance - an emerging problem.
Antiviral Research.
26:365-368.
1995
|
|
| 1995
|
Antiviral resistance in clinical practice.
Antiviral Research.
26:423-438.
1995
|
|
| 1995
|
Assays for antiviral drug resistance.
Antiviral Research.
26:403-413.
1995
|
|
| 1995
|
Models of antiviral resistance.
Antiviral Research.
26:415-422.
1995
|
|
| 1995
|
Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells
1995
|
|
| 1995
|
Molecular mechanisms of antiviral resistance.
Antiviral Research.
26:369-401.
1995
|
|
| 1995
|
Research initiatives in studies of antiviral resistance and consensus points and recommendations.
Antiviral Research.
26:439-452.
1995
|
|
